Filing Details

Accession Number:
0001225208-14-024069
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-26 12:40:47
Reporting Period:
2014-11-26
Filing Date:
2014-11-26
Accepted Time:
2014-11-26 12:40:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1082206 B Rochelle Lazarus Ogilvy &Amp; Mather
636 11Th Avenue
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-26 5,000 $34.44 9,595 No 4 M Direct
Common Stock Acquisiton 2014-11-26 5,000 $33.83 14,595 No 4 M Direct
Common Stock Disposition 2014-11-26 10,000 $59.63 4,595 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-11-26 5,000 $0.00 5,000 $34.44
Common Stock Stock Option (right to buy) Disposition 2014-11-26 5,000 $0.00 5,000 $33.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-04-28 2016-04-27 No 4 M Direct
0 2006-04-29 2015-04-28 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,757 Indirect By Spouse
Footnotes
  1. The option became exercisable in equal installments on 4/28/2007, 4/28/2008 and 4/28/2009.
  2. The option became exercisable in equal installments on 4/29/2006, 4/29/2007 and 4/29/2008.